Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Return on Sales (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Return on Sales for 2 consecutive years, with 1.64% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 328.0% to 1.64% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.76% through Dec 2025, down 84.0% year-over-year, with the annual reading at 5.75% for FY2025, 96.0% down from the prior year.
  • Return on Sales for Q4 2025 was 1.64% at Pyxis Oncology, up from 34.51% in the prior quarter.
  • The five-year high for Return on Sales was 0.33% in Q1 2024, with the low at 34.51% in Q3 2025.